Answers are grounded in this paper and cite their sources.
Multicenter survey study outlines diagnostic information needed for intermediate left main stenosis decisions among cardiologists, highlighting pathways to match expert consensus.
Background Intermediate left main (LM) lesions are among the most consequential decision points in interventional cardiology. Angiography, invasive physiology, intravascular ultrasound (IVUS) and quantitative flow ratio (QFR) are all available and supported by guidelines, yet no single diagnostic pathway is established, and decisions vary between operators. Objective To determine which level of single or combined diagnostic information brings clinical decisions in intermediate LM disease closer to an expert-level decision, defined as the full-information consensus of an interventional-expert panel. Design DECIDE-LM is an international, multicentre, case-based survey study using a pool of 40 real-world intermediate LM cases with standardised clinical vignettes; each participant assesses 20. Interventional cardiologists (≥100 PCI) are randomised (1:1:1:1:1) to one of five levels of information: angiography alone, or angiography plus invasive physiology (FFR/iFR), IVUS, QFR, or IVUS and QFR; the four arms without invasive physiology form a 2 × 2 factorial design of IVUS and QFR. Twenty senior interventional cardiologists review the complete dataset, voting first without and then with QFR; their majority decision defines the reference, and a multidisciplinary Heart Team adjudicates cases without consensus and the PCI-vs.-CABG decision. Responses are given by voice, recorded automatically in the study database and confirmed by the participant. Endpoints The primary endpoint is concordance of the decision on the LM lesion (treat vs. defer) with a graded expert reference in all 40 cases, tested in a fixed sequence: angiography plus IVUS plus QFR vs. angiography alone, then the effects of QFR and of IVUS across the factorial arms. Secondary endpoints include the other arm comparisons, treatment rate, PCI-vs.-CABG choice, the least information needed to approach expert-level decisions, and the reasons given for each decision. Assuming a gain of 5 percentage points per modality, 60 analysable participants per arm (330 randomised) provide 84% power for the QFR comparison; the sample size is re-estimated after the expert vote. Conclusions DECIDE-LM will quantify how diagnostic information shapes decisions in intermediate LM disease and how little information is needed to approach expert consensus. Results will measure agreement with expert judgement, not diagnostic accuracy or clinical utility, which would require outcome-based validation.
No takes yet. Share an insight, caveat, or question.
Ungureanu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: